PRIMARY STUDY
CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature
Key Findings: Resulting data showed that the administration of lower doses of CBD with trace amounts of THC appear to be a promising approach to manage behavioral problems associated with autism. More specifically, the authors report a decrease in behavioral problems (10 patients), an increase in expressive language (7 patients), improved cognition (4 patients), and an increase in social interaction (3 patients) for example.
Type of Study: Clinical Trial
Study Sample Size: 33
Study Result: Positive
Research Location(s): Turkey
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source: Cannabis Flower derived
Chemotype: Chemotype III
Dosage: CBD 0.3–2 mg/kg/day (with a maximum of 0.3% THC).
Route of Administration: Oral (Ingestion)
Citation: Bilge S and Ekici B. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature. J Cannabis Res. 2021; 3:53. doi: 10.1186/s42238-021-00108-7
Authors: Bilge S, Ekici B
